{"id":94593,"date":"2023-12-26T10:39:41","date_gmt":"2023-12-26T05:09:41","guid":{"rendered":"http:\/\/finservwealth.com\/aurobindo-pharma-shares-trade-lower-after-us-fda-slaps-10-observations\/"},"modified":"2023-12-26T10:39:41","modified_gmt":"2023-12-26T05:09:41","slug":"aurobindo-pharma-shares-trade-lower-after-us-fda-slaps-10-observations","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/aurobindo-pharma-shares-trade-lower-after-us-fda-slaps-10-observations\/","title":{"rendered":"Aurobindo Pharma shares trade lower after US FDA slaps 10 observations"},"content":{"rendered":"<p> The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.<\/p><div id=\"finse-3553863319\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/aurobindo-pharma-shares-trade-lower-after-us-fda-slaps-10-observations_17379171.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said. The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/aurobindo-pharma-shares-trade-lower-after-us-fda-slaps-10-observations_17379171.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/aurobindo-pharma-shares-trade-lower-after-us-fda-slaps-10-observations_17379171.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said. The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/aurobindo-pharma-shares-trade-lower-after-us-fda-slaps-10-observations_17379171.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-94593","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2021\/200x200\/a\/aurobindi-pharma_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/94593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=94593"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/94593\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=94593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=94593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=94593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}